Mark Wingertzahn

Mark Wingertzahn

Chief Tech/Sci/R&D Officer at WESANA HEALTH HOLDINGS INC.
55 year
Health Technology
Consumer Services

Profile

Mark Wingertzahn is currently an Associate Professor at the New York Institute of Technology, a Vice President-Research & Development at GlaxoSmithKline, Inc., the Head-Global Clinical Research at Pfizer Consumer Healthcare, and the Chief Scientific Officer at Wesana Health Holdings, Inc. He previously worked as the Head-Development and SVP-Research & Development at Kaleido Biosciences, Inc.

Mark Wingertzahn active positions

CompaniesPositionStart
WESANA HEALTH HOLDINGS INC. Chief Tech/Sci/R&D Officer 21/05/2021
Corporate Officer/Principal -
Chief Tech/Sci/R&D Officer -
Chief Tech/Sci/R&D Officer -

Former positions of Mark Wingertzahn

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

30

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Mark Wingertzahn